Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Blaquiere
Denis J. Blaquiere, Saskatchewan CA
| Patent application number | Description | Published |
|---|---|---|
| 20100300679 | Hydraulic Oilfield Lift Pump - A vertically orientated hydraulically driven oilfield lift pump unit having a simplified hydraulic system. The system uses a pair of single acting hydraulic cylinders in tandem with a pair of double acting hydraulic cylinders interacting with hydraulic accumulators to provide an energy efficient, robust hydraulic system design with a minimum number of components. | 12-02-2010 |
Denis J. Blaquiere, Lloydminster CA
| Patent application number | Description | Published |
|---|---|---|
| 20090078426 | Insertable Progressive Cavity Pump - A progressive cavity pump system. In an embodiment, the system comprises a tubing string disposed within a borehole. The tubing string including a seating nipple disposed at a predetermined depth in the tubing string. In addition, the system comprises a stator positioned within the tubing string. The stator includes a radially outer housing having an upper end and a lower end, a radially inner liner having a helical-shaped inner surface, a seating mandrel coupled to the upper end of the housing. Further, the system comprises a seal element disposed about the seating mandrel. The seal element forms a static seal with the inner surface of the seating nipple. | 03-26-2009 |
Nicole Blaquiere, South San Francisco, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20110076291 | BENZOXEPIN PI3K INHIBITOR COMPOUNDS AND METHODS OF USE - Benzoxepin compounds of Formula I, and including stereoisomers, geometric isomers, tautomers, solvates, metabolites and pharmaceutically acceptable salts thereof, wherein: Z | 03-31-2011 |
| 20110076292 | BENZOXAZEPIN PI3K INHIBITOR COMPOUNDS AND METHODS OF USE - Benzoxazepin compounds of Formula I, including stereoisomers, geometric isomers, tautomers, solvates, metabolites and pharmaceutically acceptable salts thereof, wherein: Z | 03-31-2011 |
